CVS Health Co. (NYSE:CVS) Shares Sold by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise cut its position in CVS Health Co. (NYSE:CVS) by 16.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,341 shares of the pharmacy operator’s stock after selling 3,102 shares during the quarter. Banque Cantonale Vaudoise’s holdings in CVS Health were worth $1,223,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atticus Wealth Management LLC grew its position in CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares in the last quarter. USA Financial Formulas grew its holdings in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in CVS Health during the 4th quarter worth approximately $32,000. Creekmur Asset Management LLC purchased a new position in CVS Health in the 4th quarter valued at approximately $34,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of CVS Health during the fourth quarter worth $36,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.7 %

Shares of NYSE CVS opened at $61.44 on Friday. The stock has a market capitalization of $77.13 billion, a price-to-earnings ratio of 10.80, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The firm has a 50-day moving average price of $60.47 and a 200 day moving average price of $70.66. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.20 earnings per share. Equities research analysts anticipate that CVS Health Co. will post 7.02 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. SVB Leerink reiterated a “market perform” rating and issued a $60.00 target price (down from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Cantor Fitzgerald restated a “neutral” rating and set a $58.00 target price on shares of CVS Health in a research note on Wednesday, June 12th. The Goldman Sachs Group decreased their price target on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Argus reduced their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, May 8th. Finally, Wells Fargo & Company lowered their target price on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 7th. Eleven equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $75.05.

Insiders Place Their Bets

In other news, Director Edward J. Ludwig purchased 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.24% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.